Bacteria: Gram-negative

Acinetobacter baumannii

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

A Gram-negative coccobacillus that survives on dry surfaces and causes healthcare-associated outbreaks.

Infections

Ventilator-associated pneumonia, bloodstream infection, wound infection, catheter-associated urinary tract infection.

Signs and symptoms

Mostly seen in hospitalized and long-term-care patients with devices. Ventilator-associated pneumonia: fever, increased secretions and falling oxygen levels. Bloodstream infection: fever, chills and low blood pressure. Wound infection, including burns and traumatic wounds: redness, drainage and wound breakdown. Colonization without symptoms is common.

Antibiotic and antimicrobial resistance

Frequently multidrug- or carbapenem-resistant (often through OXA-type carbapenemases) (carbapenemases).

Treatment considerations

Guided by susceptibility testing, usually with infectious-diseases input for carbapenem-resistant strains.

Infection control and public health

Contact precautions and environmental cleaning; carbapenem-resistant isolates are reportable in many jurisdictions.

Grey-white Acinetobacter baumannii colonies on blood agar
Acinetobacter baumannii complex colonies on blood agar. A. K. Chaurasiya; CC0. Image source
Gram-negative coccobacilli, schematic
Gram-negative coccobacilli. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Acinetobacter.
  2. IDSA. Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
  3. CDC. Healthcare-associated infections: diseases and organisms.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.